Actively Recruiting

Phase 3
Age: 18Years +
FEMALE
NCT06969326

Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

Led by Women and Infants Hospital of Rhode Island · Updated on 2025-05-13

48

Participants Needed

1

Research Sites

82 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to determine if applying a single dose of topical estrogen cream in the operating room at the end of your hysterectomy (removal of uterus and cervix) improves the postoperative experience with bleeding and potential symptoms of dysphoria (a feeling of discomfort or distress). Topical estrogen cream is sometimes used if patients have increased risk of bleeding with surgery but is not currently utilized in a consistent way. This study aims to answer the question of whether this is a helpful treatment and should be included in standard postoperative care.

CONDITIONS

Official Title

Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Gender diverse/transgender men
  • Age 18 or older
  • On testosterone therapy for at least 6 months with plan for gender-affirming hysterectomy
  • Stable physical and mental health
  • No contraindications to estrogen therapy
  • Proficient in English or Spanish
  • Access to a device to receive text messages for study follow-up
  • Agree to allow medical data use for research purposes
Not Eligible

You will not qualify if you...

  • Under age 18
  • Not on testosterone therapy for at least 6 months before planned hysterectomy
  • Known allergy to topical estrogen

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Women & Infants Hospital

Providence, Rhode Island, United States, 02905

Actively Recruiting

Loading map...

Research Team

B

Beth Cronin, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here